✦ LIBER ✦

What Ever Happened to N-of-1 Trials? Insiders' Perspectives and a Look to the Future

✍ Scribed by RICHARD L. KRAVITZ; NAIHUA DUAN; EDMUND J. NIEDZINSKI; M. CAMERON HAY; SASKIA K. SUBRAMANIAN; THOMAS S. WEISNER

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Decision-Making Perspective to Negotia

✍ Chia-Jung Tsay; Max H. Bazerman 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 107 KB

Inside the Black Box (A Simple Guide to

✍ NARANG, RISHI K 📂 Article 📅 2013 🏛 John Wiley & Sons, Inc. ⚖ 925 KB

Drug treatment: an overview of progress

✍ Kaplan, N M 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 89 KB

The Future of Hydrogeology, Then and Now

✍ Alan E. Fryar 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB

ARE N-of-1 Trials an Economically Viable

✍ Paul A. Scuffham; Michael J. Yelland; Jane Nikles; Eva Pietrzak; David Wilkinson 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 271 KB

Using aggregated single patient (N-of-1)

✍ Hugh EJ Senior, Geoffrey K Mitchell, Jane Nikles, Sue-Ann Carmont… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 195 KB